Irritable bowel syndrome.
Mertz
Howard R
HR
Department of Medicine, Division of Gastroenterology, Vanderbilt University, Nashville, USA.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D000930:Antidiarrheals / Q000627:therapeutic use; D004043:Dietary Fiber / Q000008:administration & dosage; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000523:psychology / Q000628:therapy; D008139:Loperamide / Q000627:therapeutic use; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D011613:Psychotherapy; D058831:Serotonin 5-HT3 Receptor Antagonists; D058828:Serotonin 5-HT4 Receptor Agonists; D018490:Serotonin Agents / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D000929:Antidepressive Agents, Tricyclic; D000930:Antidiarrheals; D004043:Dietary Fiber; D010276:Parasympatholytics; D058831:Serotonin 5-HT3 Receptor Antagonists; D058828:Serotonin 5-HT4 Receptor Agonists; D018490:Serotonin Agents; D012702:Serotonin Antagonists; D008139:Loperamide